ROPES WEALTH ADVISORS LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROPES WEALTH ADVISORS LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$9,000
+80.0%
103
+27.2%
0.00%0.0%
Q3 2020$5,000
+66.7%
810.0%0.00%0.0%
Q2 2020$3,000
+50.0%
810.0%0.00%0.0%
Q1 2020$2,000
-66.7%
810.0%0.00%0.0%
Q4 2019$6,000
-45.5%
810.0%0.00%
-50.0%
Q3 2019$11,000
-45.0%
81
-26.4%
0.00%
-50.0%
Q2 2019$20,0001100.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders